MedTrace Logo

Screening Hepatitis Positive Women for Congenital Anomalies

NCT03980301 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-11-03

No results posted yet for this study

Summary

Hepatitis C virus is one of the virulent viruses

Conditions

  • Hepatitis C

Interventions

DIAGNOSTIC_TEST

ultrasound

screening of pregnant women with hepatitis c virus received treatment in first trimester for congenital anomalies

Sponsors & Collaborators

  • National Research Centre, Egypt

    collaborator OTHER

  • Aljazeera Hospital

    lead OTHER

Principal Investigators

  • Mahmoud Alalfy · Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-11
Primary Completion
2020-06-15
Completion
2020-10-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03980301 on ClinicalTrials.gov